Actively Recruiting
Memory Deterioration in Alzheimer Disease
Led by Norwegian University of Science and Technology · Updated on 2025-08-12
30
Participants Needed
1
Research Sites
219 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Semantic AD
CONDITIONS
Official Title
Memory Deterioration in Alzheimer Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed diagnosis based on current ICD criteria for Alzheimer's disease or mild cognitive impairment
- Age over 55 years
- Native Norwegian speaker
- Lives at home and not in a health institution
You will not qualify if you...
- Severe cognitive impairment preventing assessment with selected modalities (planned cut-off: CDR > 2)
- Presence of brain tumors
- History of traumatic brain injury
- History of cranial surgery
- Contraindications to selected imaging modalities such as 7T MRI or EEG
- Diagnosis of other neurodegenerative diseases such as Parkinson's disease or ALS
- Large tattoos near the head, permanent makeup, or unremovable piercings
- Certain models of pacemakers (consult MRI physicist if pacemaker implanted)
- Implanted metal in the body including clips, stents, prostheses, screws, plates, or teeth
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Norwegian University of Sciene and Technology / Norges teknisk-naturvitenskapelige universitet (NTNU)
Trondheim, Trønderlag, Norway, 7030
Actively Recruiting
Research Team
A
Axel Sandvig Professor, MD & PhD
CONTACT
V
Varanann Varathalingam
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here